Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Wilms tumor of the kidney characterized by the presence of blastema, epithelial, and mesenchymal components (triphasic pattern) or a combination of two of them (biphasic pattern).
1 clinical trial registered. Interventions under study include drug therapy, other interventions, procedural interventions, and biologic therapy. Pipeline includes 1 PHASE3. Research is primarily sponsored by academic and government institutions.
10 publications have been identified in PubMed for mixed cell type kidney Wilms' tumor. Research spans Basic Science / Preclinical (30%), Gene Therapy / Novel Therapeutics (30%), and Epidemiology / Natural History (20%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 3 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 1:06 PM UTC
30%
New treatment approaches | 3 | 30% |
Disease patterns and progression | 2 | 20% |
Research summaries | 1 | 10% |
Patient case studies | 1 | 10% |
Xing ZW (2026). [PMID: 41644425](https://pubmed.ncbi.nlm.nih.gov/41644425/). *Zhonghua bing li xue za zhi = Chinese journal of pathology*. [Case Report / Case Series]
Tang Y (2026). [PMID: 41852338](https://pubmed.ncbi.nlm.nih.gov/41852338/). *Cancer biotherapy & radiopharmaceuticals*. [Gene Therapy / Novel Therapeutics]
Watzke L (2026). [PMID: 41859009](https://pubmed.ncbi.nlm.nih.gov/41859009/). *Molecular therapy. Oncology*. [Epidemiology / Natural History]
Lau BK (2026). [PMID: 41481253](https://pubmed.ncbi.nlm.nih.gov/41481253/). *Cancer research*. [Gene Therapy / Novel Therapeutics]
Hirahata T (2025). [PMID: 41171469](https://pubmed.ncbi.nlm.nih.gov/41171469/). *Clinical and experimental medicine*. [Review / Meta-Analysis]
Trink Y (2024). [PMID: 38674106](https://pubmed.ncbi.nlm.nih.gov/38674106/). *International journal of molecular sciences*. [Basic Science / Preclinical]
Xue Z (2024). [PMID: 39196923](https://pubmed.ncbi.nlm.nih.gov/39196923/). *Science advances*. [Basic Science / Preclinical]
Suwabe T (2024). [PMID: 38427208](https://pubmed.ncbi.nlm.nih.gov/38427208/). *International journal of hematology*. [Gene Therapy / Novel Therapeutics]
Ma G (2024). [PMID: 39368485](https://pubmed.ncbi.nlm.nih.gov/39368485/). *Cell reports. Medicine*. [Basic Science / Preclinical]
Zhao Z (2024). [PMID: 37922943](https://pubmed.ncbi.nlm.nih.gov/37922943/). *International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists*. [Epidemiology / Natural History]